Global Nucleic Acid Multiplex Assays Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nucleic Acid Multiplex Assays Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
Global Nucleic Acid Multiplex Assays market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical & Biotechnology Companies and Hospitals & Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Acid Multiplex Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nucleic Acid Multiplex Assays key companies include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. Abcam, Becton, Dickinson and Company are top 3 players and held % share in total in 2022.
Nucleic Acid Multiplex Assays can be divided into Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays and Other Nucleic Acid Assays,, etc. Planar Nucleic Acid Assays is the mainstream product in the market, accounting for % share globally in 2022.
Nucleic Acid Multiplex Assays is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other End Users, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Nucleic Acid Multiplex Assays industry development. In 2022, global % share of Nucleic Acid Multiplex Assays went into Pharmaceutical & Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Acid Multiplex Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nucleic Acid Multiplex Assays introduction, etc. Nucleic Acid Multiplex Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Multiplex Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Nucleic Acid Multiplex Assays market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Pharmaceutical & Biotechnology Companies and Hospitals & Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nucleic Acid Multiplex Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nucleic Acid Multiplex Assays key companies include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. Abcam, Becton, Dickinson and Company are top 3 players and held % share in total in 2022.
Nucleic Acid Multiplex Assays can be divided into Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays and Other Nucleic Acid Assays,, etc. Planar Nucleic Acid Assays is the mainstream product in the market, accounting for % share globally in 2022.
Nucleic Acid Multiplex Assays is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other End Users, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Nucleic Acid Multiplex Assays industry development. In 2022, global % share of Nucleic Acid Multiplex Assays went into Pharmaceutical & Biotechnology Companies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nucleic Acid Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nucleic Acid Multiplex Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nucleic Acid Multiplex Assays introduction, etc. Nucleic Acid Multiplex Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Multiplex Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.